{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:13:29Z","timestamp":1792872809233,"version":"4.5.0"},"reference-count":56,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2022,3,1]]},"DOI":"10.1001\/jamadermatol.2021.5743","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T11:02:53Z","timestamp":1643799773000},"page":"266","source":"Crossref","is-referenced-by-count":94,"title":["Relative Efficacy of Minoxidil and the 5-\u03b1 Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients"],"prefix":"10.1001","volume":"158","author":[{"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[{"name":"Mediprobe Research Inc, London, Ontario, Canada"},{"name":"Division of Dermatology, Department of Medicine, University of Toronto School of Medicine, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maanasa","family":"Venkataraman","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesbah","family":"Talukder","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Bamimore","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"doi210072r1","doi-asserted-by":"publisher","first-page":"781","DOI":"10.2147\/CIA.S310178","article-title":"Scalp biophysical characteristics in males with androgenetic alopecia: a comparative study with healthy controls.","volume":"16","author":"Chanprapaph","year":"2021","journal-title":"Clin Interv Aging"},{"issue":"1","key":"doi210072r2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/ajd.2007.48.issue-1","article-title":"Treatment of female pattern hair loss with a combination of spironolactone and minoxidil.","volume":"48","author":"Hoedemaker","year":"2007","journal-title":"Australas J Dermatol"},{"issue":"3","key":"doi210072r3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.det.2021.03.002","article-title":"Understanding causes of hair loss in women.","volume":"39","author":"Sadick","year":"2021","journal-title":"Dermatol Clin"},{"issue":"3","key":"doi210072r4","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13379","article-title":"5-Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety.","volume":"33","author":"Dhurat","year":"2020","journal-title":"Dermatol Ther"},{"issue":"7","key":"doi210072r5","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1111\/jdv.v35.7","article-title":"Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose.","volume":"35","author":"Villani","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"doi210072r6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/ddg.2011.9.issue-s6","article-title":"Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men.","volume":"9","author":"Blumeyer","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"doi210072r7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jdv.2018.32.issue-1","article-title":"Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version.","volume":"32","author":"Kanti","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"doi210072r8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1177\/1203475419879887","article-title":"Oral minoxidil: a possible new therapy for androgenetic alopecia.","volume":"24","author":"Gomolin","year":"2020","journal-title":"J Cutan Med Surg"},{"key":"doi210072r9","first-page":"1","article-title":"Minoxidil: a comprehensive review.","volume":"\u2022\u2022\u2022","author":"Gupta","year":"2021","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"doi210072r11","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/srt.v26.4","article-title":"Placebo-controlled dose-effect studies with topical minoxidil 2% or 5% in male-patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol.","volume":"26","author":"Van Neste","year":"2020","journal-title":"Skin Res Technol"},{"issue":"6","key":"doi210072r12","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/exd.12945","article-title":"Hair regrowth in male and female pattern hair loss does not involve the conversion of vellus hair to terminal hair.","volume":"25","author":"Hugh Rushton","year":"2016","journal-title":"Exp Dermatol"},{"issue":"135","key":"doi210072r13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range.","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"14","key":"doi210072r15","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1002\/sim.v38.14","article-title":"Incorporating single-arm evidence into a network meta-analysis using aggregate level matching: Assessing the impact.","volume":"38","author":"Leahy","year":"2019","journal-title":"Stat Med"},{"key":"doi210072r16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13643-015-0133-0","article-title":"Network meta-analysis incorporating randomized controlled trials and non-randomized comparative cohort studies for assessing the safety and effectiveness of medical treatments: challenges and opportunities.","volume":"4","author":"Cameron","year":"2015","journal-title":"Syst Rev"},{"issue":"20","key":"doi210072r17","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"key":"doi210072r19","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"doi210072r20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: An approach for assessing confidence in the results of a network meta-analysis.","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"issue":"1","key":"doi210072r21","article-title":"CINeMA: software for semiautomated assessment of the confidence in the results of network meta-analysis.","volume":"16","author":"Papakonstantinou","year":"2020","journal-title":"Campbell Syst Rev"},{"issue":"1","key":"doi210072r22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jrsm.v12.1","article-title":"The Kilim plot: A tool for visualizing network meta-analysis results for multiple outcomes.","volume":"12","author":"Seo","year":"2021","journal-title":"Res Synth Methods"},{"key":"doi210072r24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/ijd.1988.27.issue-s6","article-title":"Topical minoxidil in androgenetic alopecia Scandinavian and Middle East experience.","volume":"27","author":"Anderson","year":"1988","journal-title":"Int J Dermatol"},{"key":"doi210072r25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000248902","article-title":"2% topical minoxidil solution in male-pattern baldness: preliminary European results.","volume":"175","author":"Civatte","year":"1987","journal-title":"Dermatologica"},{"issue":"2 Pt 1","key":"doi210072r26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0190-9622(85)70157-0","article-title":"Topical minoxidil in early male pattern baldness.","volume":"13","author":"Olsen","year":"1985","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi210072r27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0190-9622(86)70138-2","article-title":"Dose-response study of topical minoxidil in male pattern baldness.","volume":"15","author":"Olsen","year":"1986","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi210072r28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1067\/mjd.2002.124088","article-title":"A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.","volume":"47","author":"Olsen","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"doi210072r29","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/ijd.1988.27.issue-s6","article-title":"The German double-blind placebo-controlled evaluation of topical minoxidil solution in the treatment of early male pattern baldness.","volume":"27","author":"Petzoldt","year":"1988","journal-title":"Int J Dermatol"},{"issue":"4","key":"doi210072r30","first-page":"555","article-title":"Clinical dose ranging studies with finasteride, a type 2 5a-reductase inhibitor, in men with male pattern hair loss.","volume":"41","author":"Roberts","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi210072r31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/ced.1989.14.issue-1","article-title":"Quantitative assessment of 2% topical minoxidil in the treatment of male pattern baldness.","volume":"14","author":"Rushton","year":"1989","journal-title":"Clin Exp Dermatol"},{"issue":"9","key":"doi210072r32","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1001\/archderm.139.9.1219-b","article-title":"Minoxidil vs finasteride in the treatment of men with androgenetic alopecia.","volume":"139","author":"Saraswat","year":"2003","journal-title":"Arch Dermatol"},{"issue":"1","key":"doi210072r33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/0378-6323.188652","article-title":"Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.","volume":"83","author":"Shanshanwal","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3 Pt 2","key":"doi210072r34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0190-9622(87)70086-3","article-title":"Dose-response study of topical minoxidil in male pattern alopecia.","volume":"16","author":"Shupack","year":"1987","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"doi210072r35","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1111\/jdv.2018.32.issue-12","article-title":"A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.","volume":"32","author":"Suchonwanit","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"doi210072r36","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/ijd.1988.27.issue-s6","article-title":"Treatment of male pattern alopecia using topical minoxidil in the Netherlands.","volume":"27","author":"Dutr\u00e9e-Meulenberg","year":"1988","journal-title":"Int J Dermatol"},{"issue":"8","key":"doi210072r37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/jde.2009.36.issue-8","article-title":"Randomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of androgenetic alopecia in Japanese men.","volume":"36","author":"Tsuboi","year":"2009","journal-title":"J Dermatol"},{"issue":"4","key":"doi210072r38","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1046\/j.1365-2133.2000.03780.x","article-title":"Finasteride increases anagen hair in men with androgenetic alopecia.","volume":"143","author":"Van Neste","year":"2000","journal-title":"Br J Dermatol"},{"issue":"1","key":"doi210072r39","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jaad.2019.08.084","article-title":"Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation.","volume":"82","author":"Pirmez","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"doi210072r40","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1007\/s13555-020-00448-x","article-title":"Efficacy and safety of oral minoxidil 5 mg once daily in the treatment of male patients with androgenetic alopecia: an open-label and global photographic assessment.","volume":"10","author":"Panchaprateep","year":"2020","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"doi210072r41","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jaad.2009.09.018","article-title":"Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study.","volume":"63","author":"Eun","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi210072r42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/0378-6323.45220","article-title":"Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia.","volume":"75","author":"Hajheydari","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"doi210072r43","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jaad.2013.10.049","article-title":"A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.","volume":"70","author":"Gubelin Harcha","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"doi210072r44","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000375320","article-title":"A single-centre, randomized, double-blind, placebo-controlled clinical trial to investigate the efficacy and safety of minoxidil topical foam in frontotemporal and vertex androgenetic alopecia in men.","volume":"28","author":"Hillmann","year":"2015","journal-title":"Skin Pharmacol Physiol"},{"issue":"4 Pt 1","key":"doi210072r45","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0190-9622(98)70007-6","article-title":"Finasteride in the treatment of men with androgenetic alopecia.","volume":"39","author":"Kaufman","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"doi210072r46","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1001\/archderm.1987.01660350083018","article-title":"Topical minoxidil therapy for androgenetic alopecia. A 30-month study.","volume":"123","author":"Koperski","year":"1987","journal-title":"Arch Dermatol"},{"issue":"6 Pt 1","key":"doi210072r47","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0190-9622(99)70081-2","article-title":"Finasteride in the treatment of men with frontal male pattern hair loss.","volume":"40","author":"Leyden","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"doi210072r48","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1111\/jde.2018.45.issue-9","article-title":"Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.","volume":"45","author":"Manabe","year":"2018","journal-title":"J Dermatol"},{"issue":"5","key":"doi210072r49","doi-asserted-by":"publisher","first-page":"622","DOI":"10.23736\/S0392-0488.19.06399-5","article-title":"Androgenetic alopecia in women and men: Italian guidelines adapted from European Dermatology Forum\/European Academy of Dermatology and Venereology guidelines.","volume":"155","author":"Alessandrini","year":"2020","journal-title":"G Ital Dermatol Venereol"},{"issue":"7","key":"doi210072r51","first-page":"56","article-title":"Adverse effects and safety of 5-alpha reductase inhibitors (finasteride, dutasteride): a systematic review.","volume":"9","author":"Hirshburg","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"issue":"1","key":"doi210072r52","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/ciia.2007.2.issue-1","article-title":"Update on the use of dutasteride in the management of benign prostatic hypertrophy.","volume":"2","author":"Miller","year":"2007","journal-title":"Clin Interv Aging"},{"issue":"4","key":"doi210072r55","first-page":"219","article-title":"Meta-analysis: pitfalls and hints.","volume":"5","author":"Greco","year":"2013","journal-title":"Heart Lung Vessel"},{"key":"doi210072r56","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2476890","article-title":"Evaluation of hair density and hair diameter in the adult Thai population using quantitative trichoscopic analysis.","volume":"2020","author":"Leerunyakul","year":"2020","journal-title":"Biomed Res Int"},{"key":"doi210072r18","doi-asserted-by":"crossref","DOI":"10.1002\/9780470743386","volume-title":"Introduction to Meta-Analysis","author":"Borenstein","year":"2009"},{"key":"doi210072r50","doi-asserted-by":"crossref","DOI":"10.1007\/978-4-431-99659-0","volume-title":"Hair Restoration Surgery in Asians","author":"Pathomvanich","year":"2010"},{"key":"doi210072r53","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/B978-0-7020-7167-6.00014-2","volume-title":"Medical Pharmacology and Therapeutics E-Book","author":"Waller","year":"2018","edition":"5th ed"},{"key":"doi210072r54","volume-title":"Basic & Clinical Pharmacology","author":"Katzung","year":"2018","edition":"14th ed"},{"key":"doi210072r10","doi-asserted-by":"crossref","unstructured":"Gupta? A, Venkataraman? M, Talukder? M, Bamimore? M. Relative efficacy of minoxidil and 5-alpha-reductase inhibitors in the treatment of male androgenetic alopecia: protocol for a network meta-analysis study. Inplasy protocol 202150083. Accessed December 21, 2021. https:\/\/inplasy.com\/inplasy-2021-5-0083\/","DOI":"10.37766\/inplasy2021.5.0083"},{"key":"doi210072r14","unstructured":"The Cochrane Collaboration. Obtaining Standard Deviations from Standard Errors and Confidence Intervals for Group Means. In: Higgins J, Green S, eds. The Cochrane Handbook. Cochrane Collaboration; 2011. Accessed December 21, 2021. https:\/\/handbook-5-1.cochrane.org\/chapter_7\/7_7_3_2_obtaining_standard_deviations_from_standard_errors_and.htm"},{"key":"doi210072r23","unstructured":"RStudio Team. RStudio: Integrated Development Environment for R. Published online 2020. Accessed December 21, 2021. https:\/\/www.rstudio.com\/"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2788258\/jamadermatology_gupta_2022_oi_210072_1646938241.66593.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T11:03:31Z","timestamp":1647428611000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2788258"}},"subtitle":["A Network Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.5743","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}